Release Date: 28/09/11 10:16 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 24.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%